Literature DB >> 12234369

Integrin activation and structural rearrangement.

Junichi Takagi1, Timothy A Springer.   

Abstract

Among adhesion receptor families, integrins are particularly important in biological processes that require rapid modulation of adhesion and de-adhesion. Activation on a timescale of < 1 s of beta2 integrins on leukocytes and beta3 integrins on platelets enables deposition of these cells at sites of inflammation or vessel wall injury. Recent crystal, nuclear magnetic resonance (NMR), and electron microscope (EM) structures of integrins and their domains lead to a unifying mechanism of activation for both integrins that contain and those that lack an inserted (I) domain. The I domain adopts two alternative conformations, termed open and closed. In striking similarity to signaling G-proteins, rearrangement of a Mg2+-binding site is linked to large conformational movements in distant backbone regions. Mutations that stabilize a particular conformation show that the open conformation has high affinity for ligand, whereas the closed conformation has low affinity. Movement of the C-terminal alpha-helix 10 A down the side of the domain in the open conformation is sufficient to increase affinity at the distal ligand-binding site 9,000-fold. This C-terminal "bell-rope" provides a mechanism for linkage to conformational movements in other domains. Recent structures and functional studies reveal interactions between beta-propeller, I, and I-like domains in the integrin headpiece, and a critical role for integrin epidermal growth factor (EGF) domains in the stalk region. The headpiece of the integrin faces down towards the membrane in the inactive conformation, and extends upward in a "switchblade"-like opening upon activation. These long-range structural rearrangements of the entire integrin molecule involving interdomain contacts appear closely linked to conformational changes within the I and I-like domains, which result in increased affinity and competence for ligand binding.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234369     DOI: 10.1034/j.1600-065x.2002.18613.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  104 in total

1.  GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice.

Authors:  Tibor Kempf; Alexander Zarbock; Christian Widera; Stefan Butz; Anika Stadtmann; Jan Rossaint; Matteo Bolomini-Vittori; Mortimer Korf-Klingebiel; L Christian Napp; Birte Hansen; Anna Kanwischer; Udo Bavendiek; Gernot Beutel; Martin Hapke; Martin G Sauer; Carlo Laudanna; Nancy Hogg; Dietmar Vestweber; Kai C Wollert
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

2.  Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit.

Authors:  Tetsuji Kamata; Hironobu Ambo; Wilma Puzon-McLaughlin; Kenneth Khiem Tieu; Makoto Handa; Yasuo Ikeda; Yoshikazu Takada
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

3.  Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics.

Authors:  Tsan Xiao; Junichi Takagi; Barry S Coller; Jia-Huai Wang; Timothy A Springer
Journal:  Nature       Date:  2004-09-19       Impact factor: 49.962

4.  Activation of integrin beta-subunit I-like domains by one-turn C-terminal alpha-helix deletions.

Authors:  Wei Yang; Motomu Shimaoka; JianFeng Chen; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

5.  Novel activating and inactivating mutations in the integrin beta1 subunit A domain.

Authors:  Stephanie J Barton; Mark A Travis; Janet A Askari; Patrick A Buckley; Susan E Craig; Martin J Humphries; A Paul Mould
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

6.  The relative influence of metal ion binding sites in the I-like domain and the interface with the hybrid domain on rolling and firm adhesion by integrin alpha4beta7.

Authors:  JianFeng Chen; Junichi Takagi; Can Xie; Tsan Xiao; Bing-Hao Luo; Timothy A Springer
Journal:  J Biol Chem       Date:  2004-09-24       Impact factor: 5.157

7.  Identification, characterization, and epitope mapping of human monoclonal antibody J19 that specifically recognizes activated integrin α4β7.

Authors:  JunPeng Qi; Kun Zhang; Qiao Zhang; Yi Sun; Ting Fu; GuoHui Li; JianFeng Chen
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

8.  Lateral mobility of individual integrin nanoclusters orchestrates the onset for leukocyte adhesion.

Authors:  Gert Jan Bakker; Christina Eich; Juan A Torreno-Pina; Ruth Diez-Ahedo; Gemma Perez-Samper; Thomas S van Zanten; Carl G Figdor; Alessandra Cambi; Maria F Garcia-Parajo
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

9.  Role of altered sialylation of the I-like domain of beta1 integrin in the binding of fibronectin to beta1 integrin: thermodynamics and conformational analyses.

Authors:  Di Pan; Yuhua Song
Journal:  Biophys J       Date:  2010-07-07       Impact factor: 4.033

10.  Chronic lymphocytic leukemia cells induce defective LFA-1-directed T-cell motility by altering Rho GTPase signaling that is reversible with lenalidomide.

Authors:  Alan G Ramsay; Rachel Evans; Shahryar Kiaii; Lena Svensson; Nancy Hogg; John G Gribben
Journal:  Blood       Date:  2013-01-16       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.